Matt Griffin has been Professor of Transplant Biology at the University of Galway’s School of Medicine and a Consultant Nephrologist at Galway University Hospitals since July 2008. He qualified in Medicine from University College Cork, Ireland in 1988 and trained in General Medicine and Nephrology in Cork, Dublin and Mayo Clinic Rochester, USA between 1989 and 1997. He pursued a research fellowship in basic immunology at The University of Chicago before returning to join the faculty of the Division of Nephrology and Hypertension and the William J von Liebig Transplant Center at Mayo Clinic from 1999 to 2008. His research interests include basic and transplant immunology, the pathophysiology and complications of kidney disease and stem cell and regenerative therapies. His research programme has been funded by the NIH, Science Foundation Ireland/Research Ireland, the Health Research Board of Ireland and the European Commission and is affiliated with the Regenerative Medicine Institute (REMEDI) and CÚRAM Research Ireland Centre for Medical Devices at University of Galway. With colleagues in REMEDI and the HRB-CRFG, he has been a trial investigator of novel cell therapies for diabetic kidney disease. He has authored over 200 peer-reviewed manuscripts to date and has been primary supervisor to over 60 postgraduate students and postdoctoral researchers, many of whom are now academic clinicians and scientists.